"One chooses whether to focus on the glass 99% full or 1% empty. Very rarely, PrEP with FTC/TDF may fail to provide full protection against rare multidrug resistant viruses," explains Dr. Grant. "If that happens, HIV treatment is highly effective."...
While the vaginal ring's overall effectiveness of 27% doesn't sound like something to get excited about, these initial results offer a proof of concept for preventing HIV in women, with hope of future open-label extension studies revealing much highe...
HIV treatment as prevention has become a well-known and powerful tool in the global HIV response. In this interview, Mark Sulkowski, M.D., discusses whether a similar approach could be used in the prevention of hepatitis C.
How do things stand with the development of topical agents for HIV prevention? In the age of oral pre-exposure prophylaxis (PrEP) and treatment as prevention, do microbicides matter anymore?
Researchers at IDWeek 2015 discussed the logistics of delivering antiretroviral therapy to all 37 million people living with HIV in the world and how to reach people during acute HIV infection.
What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.
A newly developed vaginal ring delivers a slow, continuous stream of antiretroviral drugs for at least 50 days, offering an effective HIV prevention tool for women.
Mitchell Warren, executive director of AVAC, pronounced 2015 "a really important turning point" because research proved that treatment upon diagnosis, coupled with PrEP for anyone at high risk of infection, is the best way to prevent the spread of th...
When pubic health officials debate the most effective HIV programs, generally two broad camps emerge: prevention and treatment. However, test-and-treat programs seem to offer a catchall benefit to society.
Two studies presented at IAS 2015 offered a look at factors associated with adherence to PrEP in men who have sex with men (MSM).